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A B S T R A C T
In this study, we investigated the potential protective effects of Valeriana ofﬁcinalis (V. ofﬁcinalis) against
the toxicity induced by rotenone in Drosophila melanogaster (D. melanogaster). Adult wild-type ﬂies were
concomitantly exposed to rotenone (500 mM) and V. ofﬁcinalis aqueous extract (10 mg/mL) in the food
during 7 days. Rotenone-fed ﬂies had a worse performance in the negative geotaxis assay (i.e. climbing
capability) and open-ﬁeld test (i.e. mobility time) as well as a higher incidence of mortality when
compared to control group. V. ofﬁcinalis treatment offered protection against these detrimental effects of
rotenone. In contrast, the decreased number of crossings observed in the ﬂies exposed to rotenone was
not modiﬁed by V. ofﬁcinalis. Rotenone toxicity was also associated with a marked decrease on the total-
thiol content in the homogenates and cell viability of ﬂies, which were reduced by V. ofﬁcinalis treatment.
Indeed, rotenone exposure caused a signiﬁcant increase in the mRNA expression of antioxidant enzymes
superoxide dismutase (SOD) and catalase (CAT) and also in the tyrosine hydroxylase (TH) gene. The
expression of SOD and CAT mRNAs was normalized by V. ofﬁcinalis treatment. Our results suggest that V.
ofﬁcinalis extract was effective in reducing the toxicity induced by rotenone in D. melanogaster as well as
conﬁrm the utility of this model to investigate potential therapeutic strategies on movement disorders,
including Parkinson disease (PD).
 2013 Elsevier Inc. All rights reserved.
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NeuroToxicology1. Introduction
Parkinson’s disease (PD) is the most common neurodegenera-
tive movement disorder, afﬂicting 1–2% of the population above
the age of 60 years. The pathological hallmarks of PD include
selective loss of dopaminergic neurons in the substantia nigra and
the presence of Lewy bodies in surviving dopamine neurons
(Goedert et al., 1998; Cannon and Greenamyre, 2010). Lewy bodies
are cytoplasmic inclusions composed mainly of alpha-synuclein,
which are believed to disrupt the brain’s normal functioning in PD.
Although, it is well known that environmental exposures and
individual genetic susceptibility may determine the onset of PD* Corresponding author at: Centro de Cieˆncias Naturais e Exatas, Programa de
Po´s-Graduac¸a˜o em Cieˆncias Biolo´gicas: Bioquı´mica Toxicolo´gica, 97105-900 Santa
Maria, RS, Brazil. Tel.: +55 55 3220 8140; fax: +55 55 3220 8978.
E-mail addresses: jbtrocha@yahoo.com.br (J.B.T. Rocha),
nvbarbosa@yahoo.com.br (N.V. Barbosa).
1 In memorian.
0161-813X/$ – see front matter  2013 Elsevier Inc. All rights reserved.
http://dx.doi.org/10.1016/j.neuro.2013.04.006symptoms; the precise cellular and molecular mechanism(s)
responsible for the neurodegeneration processes remain still
unknown. However, free radical overproduction and abnormalities
in mitochondria function have emerged as critical mediators of the
neuronal damage in PD (Sherer et al., 2002; Coulom and Birman,
2004; Rama Rao et al., 2007; Valko et al., 2007). Knowing that
oxidative stress plays a central role in PD disease; numerous
studies have been conducted to investigate the potential
neuroprotective action of antioxidants in neurotoxin-based
models of PD. Though several synthetic antioxidants are available,
a growing trend has been targeting medicinal plants as antiox-
idants since herbal compounds empirically used in folk medicine
are generally free of adverse effects.
The root extracts of Valeriana ofﬁcinalis (V. ofﬁcinalis L.,
Valerianaceae) have been used for centuries in popular medicine
for the treatment of sleep disorders, anxiety and epilepsy (Hadley
and Petry, 2003). V. ofﬁcinalis can modulate anxiety and insomnia
by interacting with different neurotransmitter systems (Malva
et al., 2004; Ortiz et al., 2006; Sichardt et al., 2007; Sudati et al.,
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limited data on the possible protective effect of V. ofﬁcinalis in
neurodegeneration.
Regarding to PD, it is well recognized that the rotenone model of
PD reproduces some important aspects of the pathology (Coulom
and Birman, 2004; Cannon and Greenamyre, 2010). However, this
model has limitations that are mainly related to the variability of
percentage of animals that development nigrostriatal lesion and
the level of lesion (Cannon and Greenamyre, 2010). Consequently,
there is a need for improvement of current models and
development of new experimental models. It has been amply
accepted the use of the fruit ﬂy Drosophila melanogaster (D.
melanogaster) as a model to study molecular mechanisms involved
in neurological diseases, including PD (Nichols, 2006; Hirth, 2010;
Rand, 2010; Girish and Muralidhara, 2012). Notably, the ﬂy has
homology among ﬁve of the six genes related to PD in humans
(Whitworth et al., 2006). In view of the probable advantages of the
rotenone model on ﬂies in terms of reproducibility and experi-
mental design, we aimed to investigate the possible protective
effects of V. ofﬁcinalis on rotenone-induced toxicity in D.
melanogaster. Speciﬁcally, we evaluated the potential of V.
ofﬁcinalis powder root in attenuating lethality, toxicity, movement
disorders and some biochemical parameters of oxidative stress
induced by rotenone exposure in ﬂies.
2. Materials and methods
2.1. Chemicals
Rotenone, 5,50-dithiobis-(2-nitrobenzoic acid) (DTNB), 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT),
Ampliﬂu red ﬂuorescent dye and Horseradish peroxidase were
obtained from Sigma Chemical Company (St Louis, MO, USA).
2.2. Plant material
Powder from roots of V. ofﬁcinalis was obtained from Bio
extracts (Sa˜o Paulo, Brazil). Aqueous extract was obtained after
15 min of infusion using water.
2.3. Drosophila stock
D. melanogaster wild-type was obtained from the National
species Stock Center, Bowling Green, OH, USA. The ﬂies were
reared on agar medium (1%, w/v brewer’s yeast; 2%, w/v sucrose;
1%, w/v powdered milk; 1%, w/v agar; 0.08%, v/w nipagin) at
constant temperature and humidity (23  1 8C; 60% relative
humidity, respectively). The ﬂies were reared in 2.5 cm  6.5 cm
vials containing 5 mL of medium at constant temperature, humidity
(60%) and under 12 h dark/light cycle. All experiments were
performed with the same strain.
2.4. Rotenone exposure and V. ofﬁcinalis treatment
Flies (both gender, 1–2 days old) were divided into four groups:
(1) control; (2) rotenone; (3) V. ofﬁcinalis and (4) rotenone plus V.
ofﬁcinalis. Rotenone (dissolved in ethanol 98%) and V. ofﬁcinalis
(aqueous extract) were added into the food’s ﬂies at ﬁnal
concentration of 500 mM and 10 mg/mL, respectively. The total
food medium contained a volume of 1% of ethanol, V. ofﬁcinalis
aqueous extract, rotenone or rotenone plus V. ofﬁcinalis. Two
controls were used (with and without ethanol). However, only the
ethanol control is showed in the results because there was no
statistical difference between these groups in all parameters
evaluated. The ﬂies were exposed to treatments during 7 days
(Moreira et al., 2012) and the vials containing ﬂies weremaintained in an incubator at 23  1 8C before being used for
different assays. The concentration of rotenone used in this protocol
was based on a survival curve (0.1, 0.5 and 1 mM), and corresponds to
the concentration that caused approximately 50% death of the ﬂies
after 7 days of exposure (data not shown). The choice of V. ofﬁcinalis
aqueous extract concentration was based on previous observations,
which showed that V. ofﬁcinalis aqueous extract in the range of 5–
20 mg/mL did not cause overt signals of toxicity in ﬂies (data not
shown).
2.5. Valeric acid, gallic acid, ellagic acid and quercetin quantiﬁcation
High performance liquid chromatography (HPLC-DAD) of
aqueous extract of V. ofﬁcinalis was performed with the HPLC
system (Shimadzu, Kyoto, Japan), according to a previous work
from our group (Sudati et al., 2009). Brieﬂy, stock solutions of
valeric acid, gallic acid, ellagic acid and quercetin standard
reference were prepared in the HPLC mobile phase at a
concentration range of 3.12–50.0 mg/mL. Quantiﬁcation was
carried out by the integration of the peaks using external standard
method at 220 nm for valeric acid, 257 nm for gallic acid, 325 nm
for ellagic acid and 356 for quercetin. The ﬂow rate was 1.5 mL/min
and the injection volume was 10 ml. The chromatographic peaks
were conﬁrmed by comparing their retention time and DAD-UV
spectra (200–400 nm) and with those of the reference standards.
All chromatographic operations were carried out at ambient
temperature and in triplicate.
2.6. In vivo assays
2.6.1. Survival rate
The survival rate was evaluated by counting daily of the number
of living ﬂies until the end of the experimental period (7 days).
Around 150 ﬂies per group were included in the survival data and
the total number of ﬂies represents the sum of three independent
experiments (50 ﬂies/each treatment repetition).
2.6.2. Negative geotaxis
Locomotor ability of ﬂies was performed with a negative
geotaxis assay as described previously by Feany and Bender (2000).
The ﬂies (both gender) were sorted under a brief ice anesthesia and
placed in a vertical glass column (length: 10 cm, diameter: 1.5 cm/
5 ﬂies each). After the recovery from cold exposure (approximately
20 min) the ﬂies were gently tapped to the bottom of the column.
The ﬂies that reached the top of the column (6 cm) and the ﬂies
that remained at the bottom were counted separately during 6 s.
The scores represent the mean of the numbers of ﬂies at the top
(ntop) as percentage of the total number of ﬂies (ntot). Around 15
ﬂies per group were included for the negative geotaxis data (total
of 45 ﬂies). This value represents the sum of three independent
experiments.
2.6.3. Open-ﬁeld
Open-ﬁeld task was performed according to the method
described by Hirth (2010), with some modiﬁcations. Each wild-
type ﬂy was kept in an arena divided by squares (1 cm  1 cm)
measuring 9 cm of diameter, which can be covered by petri dish.
The ﬂy’s activity and movement were recorded with a video
camera and the distance travelled was recorded by the resulting
trajectory during a given time-window (60 s), which was
calculated throughout the number of squares crossed by each
single ﬂy analyzed. Video-assisted movement tracking records
locomotor behavior allows the quantiﬁcation of immobility (time
spends without locomotion) and distance travelled (number of
square crossed). Around 15 ﬂies were included for each treatment
performed and the total number of ﬂies contained in the open-ﬁeld
J.H. Sudati et al. / NeuroToxicology 37 (2013) 118–126120data (45 per group) represents the sum of three independent
experiments.
2.7. Ex vivo assays
2.7.1. Homogenate preparation
About 20 ﬂies per group were immobilized by chilling on ice
and then decanted into a chilled mortar. Whole body of ﬂies was
manually homogenized in ice-cold Tris/HCl buffer (pH 7.4, 0.1 M),
1:10 (ﬂies/volume (mL)). The homogenate was ﬁltered through
sieve with nylon mesh (pore size/10 mm), centrifuged at 3000  g
for 3 min at 4 8C, and the supernatant was used for biochemical
assays (20 ﬂies/200 mL).
2.7.2. RNA Isolation and analysis of mRNA expression by q-PCR
(quantitative real-time PCR)
Approximately 2 mg of total RNA from 20 ﬂies per group was
extracted using Trizol1 reagent (Invitrogen1) according to the
manufacturer’s suggested protocol. The primers sequences for
genes of Catalase (CAT), superoxide dismutase (SOD) and tyrosine
hydroxylase (TH) were designed. Gene speciﬁc primer sequences
were based on published sequences in GenBank Overview (http://
www.ncbi.nlm.nih.gov/genbank/) designed with Primer3 pro-
gram version 0.4.0 (http://frodo.wi.mit.edu/primer3/) and cus-
tom made by Invitrogen1 (Table 1). After quantiﬁcation, total RNA
was treated with DNase I (Invitrogen1). The cDNA was
synthesised with M-MLV reverse transcriptase enzyme and
random primer (Invitrogen) according to the manufacturer’s
suggested protocol. Quantitative real-time polymerase chain
reaction was performed in 20 mL PCR mixture containing 1 ml RT
product (cDNAs) as template, 1 PCR buffer, 25 mM dNTPs,
0.2 mM of each primer, 1.5–2.5 mM MgCl2, 0.1 SYBR Green I
(Molecular Probes1) and 1 U Taq DNA polymerase (Invitrogen1)
(Golombieski et al., 2008). The thermal cycle was carried in a
Thermocycler StepOne Plus (Applied Biosystems) and the proto-
col used was the following: activation of the Taq DNA polymerase
95 8C for 5 min followed of 40 cycles of 15 s at 95 8C, 15 s at 60 8C
and 25 s at 72 8C. SYBR ﬂuorescence was analyzed by StepOne
software version 2.0 (Applied Biosystems), and the CT value for
each sample was calculated and reported using the 2DDCT
method described by Livak and Schmittgen (2001). For each well,
analyzed in quadruplicate, a DCT value was obtained by
subtracting the actin and GPDH CT value from the C T value of
the interest gene. The DCT mean value obtained from the control
group of each gene was used to calculate the DDCT of the
respective gene (2DDCT). All experiments were calculated in
relation to both gene controls: tubulin and GPDH. Three
independent experiments were performed with 20 ﬂies collected
and qPCR quantiﬁcation was performed in quadruplicate.Table 1
Sequences of qPCR primers.
Primer Sequence
Sod LEFT 50 GGAGTCGGTGATGTTGACCT 30
Sod RIGHT 50 GTTCGGTGACAACACCAATG 30
Catalase LEFT 50 ACCAGGGCATCAAGAATCTG 30
Catalase RIGHT 50 AACTTCTTGGCCTGCTCGTA 30 ’
TH LEFT 50 TACAAGCCCACGGAGTTCTT 30
TH RIGHT 50 GTCAGGCCAGACTTCAAAGC 30
GPDH LEFT 50 ATGGAGATGATTCGCTTCGT 30
GPDH RIG HT 50 GCTCCTCAATGGTTTTTCCA 30
Tubulin LEFT 50 ACCAATGCAAGAAAGCCTTG 30
Tubulin RIGHT 50 ATCCCCAACAACGTGAAGAC 302.7.3. Cell viability evaluation
Cell viability was evaluated by dehydrogenase activity using the
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) reduction assay. This analysis was performed in whole
body of ﬂies by two different manners (with and without
homogenate procedure), according to the method described by
Babot et al. (2005). The ratio values were standardized per protein
content and expressed as percentage in relation to the control.
2.7.4. Thiol determination
Total and non-protein thiol contents were estimated based on a
spectrophotometric method using Ellman’s reagent, DTNB (5,50-
dithiobis-(2-nitrobenzoic acid) (Ellman, 1959). For non-protein
thiol, the homogenate was precipitated with TCA 10% followed by
centrifugation at 3000  g for 3 min at 4 8C. The supernatant
samples were measured spectrophotometrically at 412 nm. A
standard curve was constructed for each measurement using GSH.
Thiol levels were expressed as percentage in relation to the control.
2.7.5. Isolation of mitochondria
After the treatment (described previously), mitochondria from
D. melanogaster were isolated according to Miwa and Brand (2005),
with minor modiﬁcations. Brieﬂy, about 50 ﬂies were immobilized
by chilling on ice, and gently pressed with a pestle in a chilled
mortar containing a little isolation medium (250 mM sucrose,
5 mM Tris–HCl, 2 mM EGTA, 1% (w/v) bovine serum albumin,
adjusted to pH 7.4 at 4 8C) then passed through absorbent muslin
and collected into a tube (1.5 mL) and immediately centrifuged at
150  g for 3 min at 4 8C. The supernatant was passed through one
layer of muslin and recentrifuged at 9000  g for 10 min. The
supernatant was discarded and the pellet was carefully resus-
pended in isolation medium to give about 30 mg protein/mL. The
detailed characteristics of mitochondria prepared on this way were
previously reported by Miwa et al. (2003). The experiments were
started as soon as possible after the isolation procedure.
2.7.6. Measurement of mitochondrial H2O2 production
H2O2 released from mitochondria was detected using the
Ampliﬂu red ﬂuorescent dye, which reacts with H2O2 in the presence
of Horseradish peroxidase, producing highly ﬂuorescent resourcing.
Horseradish peroxidase (0.2 U/mL) and Amplifu red reagent (1 mM)
were added to the assay medium and then mitochondria (0.1 mg/
mL) were applied. H2O2 formation was initiated by the addition of
pyruvate (5 mM) and ﬂuorescence was detected at 30 8C in a
Shimadzu spectrophotometer. The excitation and emission ﬂuores-
cent wavelengths were 550 and 585 nm, slit (3 and 5) respectively.
The positive control signal was produced by the addition of known
amounts of H2O2 at the end of each experiment.
2.7.7. Protein determination
Protein concentrations in the whole body homogenates were
determined by the method of comassie blue (Bradford, 1976),
using bovine serum albumin as the standard.
2.8. Statistical analyses
Behavior and survival data were evaluated by nonparametric
methods because Levene’s test indicated the absence of Homoge-
neity of Variance. Behavior parameters were analyzed using
Kruskal–Wallis (kw) followed by Dunn’s multiple comparisons test
when appropriate and survival by the x2method and Fisher’s exact
test (ESTATISTIC Module Switcher Program). All other results were
analyzed by two-way ANOVA followed by Duncan multiple range
test when appropriate. Differences between groups were consid-
ered signiﬁcant when p < 0.05. Data of non-parametric analysis are
represented as medians and ranges (interquartile interval); and
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created using GraphPad Prisma 4.0.
3. Results
3.1. HPLC analyses
HPLC ﬁngerprinting of the aqueous extract of V. ofﬁcinalis
(10 mg/mL) showed an elution diagram when the peaks were
grouped in regions based on the UV absorption proﬁle (Fig. 1). The
chromatograms of aqueous extract revealed a peak 2 with a
retention time (r.t.) at 2.55 min corresponding to valeric acid
(y = 668.6x + 3.361, r = 0.9960) in the concentration of 2.29 mg/mL.
Indeed, it was found a peak 3 (r.t. = 4.39 min), corresponding to
ellagic acid (y = 328.4x + 2.196, r = 0.9997) at concentration of
0.71 mg/mL; a peak 4 (r.t. = 5.32 min) corresponding to gallic acid
(y = 245.7x + 1.480, r = 0.9998) at concentration of 0.47 mg/mL and
a peak 5 (r.t. = 8.66 min) supporting the presence of quercetin
(y = 258.3x + 1.537, r = 0.9999) at concentration of 0.11 mg/mL.Fig. 1. (A) High performance liquid chromatography of V. ofﬁcinalis aqueous extract; peak
acid, peak 4: gallic acid and peak 5: quercetin. (B) Representative chromatogram of vale
chromatogram of acid gallic standard (peak 4) and (E) chromatogram of quercetin stan3.2. Effect of V. ofﬁcinalis on survival rate of ﬂies exposed to rotenone
Data of Fig. 2 show that rotenone exposure caused a time
dependent increase in the percentage of deaths until the end of
experimental period when compared to the control group. The
mortality rate was lower in the ﬂies treated simultaneously with V.
ofﬁcinalis. V. ofﬁcinalis alone did not alter the survival of the ﬂies
when compared to the control group (Fig. 2).
3.3. Effect of V. ofﬁcinalis on negative geotaxis assay in the ﬂies
exposed to rotenone
Dunn’s multiple comparisons test revealed that the climbing
behavior was impaired in the ﬂies exposed to rotenone, when
compared to control ﬂies (kw = 10.77; p = 0.029; Fig. 3). This effect
of rotenone was abolished by V. ofﬁcinalis treatment. Statistical
analysis also showed that there was not signiﬁcant difference in
this parameter between V. ofﬁcinalis alone and control group
(kw = 10.77; p > 0.05). 1: represents an unknown peak, peak 2: corresponds to valeric acid, peak 3: ellagic
ric acid standard (peak 2), (C) chromatogram of ellagic acid standard (peak 3), (D)
dard. Chromatographic conditions are described in Section 2.
Fig. 2. Effect of V. ofﬁcinalis on survival rate of ﬂies exposed to rotenone. Data were
collected every 24 h for each group during 7 days. The numbers of surviving ﬂies are
represented as % of control. The total number of ﬂies (150 per group) represents the
sum of three independent experiments. *Signiﬁcant difference in relation to the
control group (Fischer’s exact probability test). Values are expressed as median and
range (interquartile interval).
Fig. 3. Effect of V. ofﬁcinalis on geotaxic response (climbing) of ﬂies exposed to
rotenone during 7 days. The total number of ﬂies (45 per group) represents the
sum of three independent experiments (15 ﬂies/each analysis). Values are
expressed as median and range (interquartile interval). *Signiﬁcant difference in
relation to the control group; #Signiﬁcant difference between Rot and Rot + Val
groups (Kruskal–Wallis test followed Dunn’ multiple comparisons test, p < 0.05).
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rotenone
In open-ﬁeld evaluation, Kruskal–Wallis test followed by
Dunn’s multiple comparisons test revealed that the ﬂies exposed
to rotenone had a signiﬁcant decrease in the number of crossings
(kw = 50.66; p = 0.0001) when compared to the control group and
that this effect was not modiﬁed by concomitant treatment with V.
ofﬁcinalis (kw = 50.66; p > 0.05) (Fig. 4A). No signiﬁcant difference
was observed between V. ofﬁcinalis and control group in this
parameter (kw = 50.66; p > 0.05).
Dunn’s multiple comparisons test revealed that the immobility,
evaluated by time spent without moving, was signiﬁcantly
increased in the ﬂies exposed to rotenone (kw = 17.90;
p = 0.0013) when compared to control group (Fig. 4B). This effect
of rotenone was blunted by V. ofﬁcinalis treatment. Kruskal–Wallis
test also indicated that there was no signiﬁcant difference between
V. ofﬁcinalis and control group in this evaluation (kw = 17.90;
p > 0.05).
3.5. mRNA expression of SOD, CAT and TH genes
Two-way ANOVA followed by post hoc comparisons showed
that ﬂies exposed to rotenone had a signiﬁcant increase in the
mRNA expression of SOD (Fig. 5A) and CAT (Fig. 5B), whenFig. 4. Effect of V. ofﬁcinalis on locomotor and exploratory activities evaluated by open-ﬁe
activity (evaluated by counting the crossing numbers) and (B) immobility time. The 
experiments. Values are expressed as median and range (interquartile interval). *Signiﬁ
and Rot + Val groups (Kruskal–Wallis test followed Dunn’ multiple comparisons test, pcompared to the values found in the control group. These effects
induced by rotenone exposure on antioxidant genes were
normalized by V. ofﬁcinalis treatment. The mRNA expression of
CAT was increased in the ﬂies treated with V. ofﬁcinalis alone
(Fig. 5B). Statistical analysis revealed a signiﬁcant main effect of
rotenone [F(1,8) = 13.65, p < 0.0061] on SOD and V. ofﬁcinalis on
CAT mRNA expression [F(1,8) = 5.57, p < 0.046]. Indeed, a signiﬁ-
cant rotenone  V. ofﬁcinalis interaction was veriﬁed in both SOD
[F(1,8) = 13.55, p < 0.006] and CAT [F(1,8) = 26.7, p < 0.0009]
mRNA expression.
Rotenone exposure also caused an increase on mRNA expres-
sion of TH, which was not restored by concomitant treatment with
V. ofﬁcinalis (Fig. 5C). In this parameter, there was a signiﬁcant
main effect of V. ofﬁcinalis [F(1,8) = 32.65, p < 0.0004]. No
signiﬁcant interaction between rotenone and V. ofﬁcinalis was
observed on mRNA TH expression [F(1,8) = 1.574.90, p < 0.038].
3.6. Effect of V. ofﬁcinalis on MTT reduction in homogenate and body
region of ﬂies exposed to rotenone
Two-way ANOVA followed by post hoc comparisons showed
that rotenone exposure caused a signiﬁcant decrease on MTTld of the ﬂies exposed to rotenone. Two parameters were analyzed: (A) exploratory
total number of ﬂies (50 per group) represents the sum of three independent
cant difference in relation to the control group; #signiﬁcant difference between Rot
 < 0.05).
Fig. 5. qPCR relative gene expression of superoxide dismutase (SOD) graph A, catalase (CAT), graph B and tyrosine hydroxylase (TH), graph C. Results are expressed as
mean  S.E.M (n = 3). The experiment was done from 3 independent homogeneization of 20 ﬂies each, and qPCR quantiﬁcation was performed in quadruplicate. *Signiﬁcant
difference in relation to control group; #signiﬁcant difference between Rot and Rot + Val groups (p < 0.05, two-way ANOVA followed Duncan multiple range test).
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by V. ofﬁcinalis treatment (Fig. 6). Indeed, statistical analysis
revealed a main effect of V. ofﬁcinalis [F(1,20) = 4.90, p < 0.038].
Rotenone  V. ofﬁcinalis interaction was not signiﬁcant on MTT
reduction [F(1,20) = 2.21, p < 0.15].Fig. 6. Effect of V. ofﬁcinalis on cell viability in homogenate of ﬂies exposed to
rotenone. *Signiﬁcant difference in relation to control group. Values are expressed
as mean  S.E.M (n = 9). #Signiﬁcant difference between Rot and Rot + Val groups
(p < 0.05, two-way ANOVA followed by Duncan multiple range test).To check if the homogenization procedure could inﬂuence these
results, we performed the same assay without homogenizing the
ﬂies. As observed with homogenates, MTT reduction in entire ﬂies
was decreased by rotenone and this effect was abolished by V.
ofﬁcinalis treatment (data not shown).
3.7. Effect of V. ofﬁcinalis on thiol content in homogenate of ﬂies
exposed to rotenone
Two-way ANOVA followed by post hoc comparisons showed
that rotenone exposure diminished signiﬁcantly the total-thiol
content of the ﬂies when compared to the control group (Fig. 7A). V.
ofﬁcinalis treatment blunted the rotenone-induced decrease on the
total-thiol content in the ﬂies. Statistical analysis also indicated a
signiﬁcant main effect of V. ofﬁcinalis on thiol levels
[F(1,12) = 10.48, p < 0.007]. No signiﬁcant main effect of rotenone
[F(1,12) = 0.06, p < 0.98] and/or rotenone  V. ofﬁcinalis interac-
tion [F(1,12) = 0.25, p < 0.628] was found in this parameter.
No signiﬁcant difference was observed among the groups on the
non-protein thiols levels (Fig. 7B).
3.8. Effect of V. ofﬁcinalis on H2O2 mitochondrial production in
mitochondria of ﬂies exposed to rotenone
Two-way ANOVA followed by post hoc comparisons showed
that H2O2 mitochondrial formation was increased in the ﬂies
exposed to rotenone (line d and inset columns) compared to
Fig. 7. Effect of V. ofﬁcinalis on total-thiol (A) and non-protein thiol (B) content in homogenate of ﬂies exposed to rotenone. *Signiﬁcant difference in relation to control group;
#signiﬁcant difference between Rot and Rot + Val groups. Values are expressed as mean  S.E.M (n = 9) (p < 0.05, two-way ANOVA followed by Duncan multiple range test).
J.H. Sudati et al. / NeuroToxicology 37 (2013) 118–126124control group (line b; p < 0.05). The rotenone-induced over
production of H2O2 was reduced by V. ofﬁcinalis treatment (line
e and inset, Fig. 8). Indeed, a signiﬁcant main effect of V. ofﬁcinalis
[F(1,12) = 10.44, p < 0.007] and rotenone  V. ofﬁcinalis interaction
[F(1,12) = 4.75, p < 0.05] was veriﬁed on H2O2 mitochondrial
levels.
4. Discussion
Currently, D. melanogaster has been used as an alternative
animal model for screening of natural therapeutic agents for the
treatment of neurodegenerative diseases, including PD (Hosamani
and Muralidhara, 2009; Jeibmann and Paulus, 2009). With this in
mind, the present study was delineated to evaluate the possible
beneﬁcial effects of V. ofﬁcinalis against the toxicity related to the
rotenone exposure in D. melanogaster. We have found that the
aqueous extract from roots of V. ofﬁcinalis was effective in reducing
motor impairments and some oxidative stress parameters
mediated by rotenone.
In our experimental protocol, exposure of D. melanogaster to
rotenone reproduced key aspects of PD, for instance locomotor
deﬁcits. In fact, the ﬂies exposed to rotenone exhibited impairment
in negative geotaxis (climbing) and in the open-ﬁeld test (crossing
numbers and immobility time). Interestingly, most of theseFig. 8. Hydrogen peroxide (H2O2) production of isolated mitochondria from D.
melanogaster. (A) probe alone, (B) control, (C) Val, (D) Rot and (e) Rot + Val.
*Signiﬁcant difference in relation to control group; #signiﬁcant difference between
Rot and Rot + Val groups. Lines correspond to a randomly representative graphic.
Values are expressed as mean  S.E.M (n = 3) (p < 0.05, two-way ANOVA followed by
Duncan multiple range test).movement disturbances were ameliorated by V. ofﬁcinalis treat-
ment. Indeed, V. ofﬁcinalis reduced the mortality rate of the ﬂies
exposed to rotenone. These beneﬁcial effects of V. ofﬁcinalis
observed here are in accordance with the data of a recent study
where the plant was able in avoiding oral movement deﬁcits
induced by reserpine in rats (Pereira et al., 2011).
A growing body of evidence suggests that the exposure to
neurotoxins such as rotenone, paraquat and/or MPTP (1-methyl-4-
phenyl-1,2,3,6-tetrahydropyridine) can lead to the PD like
pathology and symptoms (Valko et al., 2007; Cicchetti et al.,
2009; Goldman et al., 2012). Although, little is known about the
precise mechanism action of these agents in D. melanogaster; the
involvement of mitochondrial complex I, is well supported by
several experimental studies (Cicchetti et al., 2009; Norenberg and
Rao, 2007). Indeed, there is clue that these pesticides can induce
Lewy bodies formation, dopaminergic neurodegeneration, de-
crease in striatal dopamine levels and disturbances in GSH
homeostasis (Garrido et al., 2011). Alterations in gene expression
like tyrosine hydroxylase, alpha-synuclein, PARKIN, PINK1 or DJ-1,
which are involved in the sporadic forms of PD, have also been
associated with the toxicity of rotenone and MPTP (Rajput and
Rajput, 2007). Thus, it is widely accepted that the effects mediated
by rotenone encompass oxidative stress linked with mitochondrial
dysfunction and reactive oxygen species (ROS) overproduction
(Cicchetti et al., 2009).
Here we observed that rotenone exposure increased the mRNA
expression of antioxidant enzymes (SOD and CAT) and TH, which
may represent a compensatory response to oxidative insults. Here
we have not determined concomitantly the levels and/or activity of
respective enzymes; and this fact could limit an analysis more
detailed of our results. However, accompanied or not by changes in
the activity of enzymes, it is reasonable assume that rotenone
inﬂuences the transcription of SOD and CAT enzymes genes.
Indeed, rotenone reduced signiﬁcantly the cell viability and the
total-thiol content, without changing the non-protein thiol levels
in the ﬂies. Taken together, these data suggest a possible
implication of oxidative stress on the rotenone-based model with
D. melanogaster.
It is well established that V. ofﬁcinalis is a medicinal plant
effective in improving anxiety and sleep disorders (Hadley and
Petry, 2003). However, few investigations have evaluated the
effects of V. ofﬁcinalis in experimental neurodegenerative diseases.
In fact, we found only one study in the literature pointing a
cytoprotective role for V. ofﬁcinalis extracts in an in vitro model of
PD (Oliveira et al., 2009). In this sense, our data show, for the ﬁrst
time, the effectiveness of V. ofﬁcinalis in reducing the deleterious
effects of rotenone in both behavior and oxidative stress
J.H. Sudati et al. / NeuroToxicology 37 (2013) 118–126 125parameters after in vivo exposure of D. melanogaster. It is
reasonable to assume that the protection offered by V. ofﬁcinalis
in behavior and biochemical parameters is, at least in part,
associated with antioxidant properties of plant due to its phenolic
and ﬂavonoid constituents. Corroborating this idea, there is
evidence that V. ofﬁcinalis tincture is effective in inhibiting
thiobarbituric acid reactive substances production and deoxyri-
bose degradation stimulated by different pro-oxidants in brain rats
(Sudati et al., 2009).
Although our study did not encompass the neuroactive role of V.
ofﬁcinalis in terms of mechanisms, it is important to mention here
that both valerenic acid (a major constituent of Valerian root
extracts) and herbal extracts of V. ofﬁcinalis may enhance GABA
responses (Neuhaus et al., 2008; Tariq and Pulisetty, 2008). In PD
and its animal models, it is believed that GABA signalizing is critical
for the function of the basal ganglia given its ability in modulating
dopaminergic neurons (Denora et al., 2012). In accordance, studies
have showed that the severity of tremor in PD patients is correlated
with abnormalities found in GABA receptor density and binding
(Gironell, 2007; Gironell et al., 2012). Speciﬁcally with D.
melanogaster, a recent study demonstrated the participation of
GABAB receptor in the etiology of PD in a model using transgenic
ﬂies carrying the human gene for alpha synuclein (Hillman et al.,
2012). Consequently, it is plausible suppose that the gabaergic
action of V. ofﬁcinalis could be contributing to its pharmacological
effects on the rotenone model of PD in D. melanogaster. Supporting
this proposal, current literature ﬁndings have pointed gabaergic
agonists for dopamine replacement therapy (Leal et al., 2004;
Denora et al., 2012; Hillman et al., 2012).
In summary, the results of present study show that V. ofﬁcinalis
extract is efﬁcacious in reducing the toxicity induced by rotenone
in D. melanogaster as well as conﬁrm the utility of this model to
investigate therapeutic strategies that may be promising in
treatment of neurodegenerative diseases. However, additional
studies about the neurological pathways involved on the protec-
tive role of V. ofﬁcinalis in PD will be needed. Besides, epidemio-
logical researches should be performed to determine whether the
use of V. ofﬁcinalis in folk medicine is associated or not with a
decrease in the incidence of PD.
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